Amarantus Bioscience (AMBS) is a "penny stock" company that owns the patented MANF technology. The company had huge potential before the recent announcement regarding the "Human Brain Mapping Project". Take the time to investigate the company and its potential to be a huge contributor in the treatment of diseases such as Parkinson's Disease. The company has already been awarded several grants from the Michael J. Fox Foundation for research in this area.